CARS1 and cancer: For the clinical application of CAR exosomes, the proposed scheme includes T-cell isolation from the peripheral blood of healthy donors or cancer patients, genetic engineering of T cells to express CARs, in vitro replication and stimulation of CAR-engineered T cells, isolation of exosomes, purification of CAR exosomes, and exosome infusion into patients.